Stranded Pigs Rescued By NZ Biotech, Helicon SFDA Approval For Skin Regeneration Device, Arana Ramps Up R&D - Australia/New Zealand Roundup
This article was originally published in PharmAsia News
Executive Summary
Stranded New Zealand Pig Herd Could Offer Better Treatments For Diabetes
You may also be interested in...
New Zealand's Living Cell Technologies Cleared For Phase II Diabetes Trials As Pig Herd Becomes More Famous
PERTH, Australia - Auckland-based Living Cell Technologies received the green light from New Zealand regulators to proceed with Phase II clinical trials of its lead product Diabecell, based on encapsulated pig insulin-producing cells aimed at normalizing blood glucose levels for people with type 1 diabetes
New Zealand's Living Cell Technologies Cleared For Phase II Diabetes Trials As Pig Herd Becomes More Famous
PERTH, Australia - Auckland-based Living Cell Technologies received the green light from New Zealand regulators to proceed with Phase II clinical trials of its lead product Diabecell, based on encapsulated pig insulin-producing cells aimed at normalizing blood glucose levels for people with type 1 diabetes
J&J Subsidiary Centocor Extends Collaboration With New Zealand's Living Cell Technologies For Encapsulation Technology
PERTH, Australia - Johnson & Johnson subsidiary Centocor has extended its two-year research collaboration with New Zealand-based Living Cell Technologies, and signed on for an exclusive two-year option to license globally LCT's encapsulation technology for human cell lines